Pursuant to Regulation 29 and other applicable provisions, if any, of the Securities and Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015, Mangalam Drugs & Organics has informed that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday, August 12, 2021 at the registered office of the Company at Mumbai, to consider and approve the Un-Audited Financial Results of the Company for the quarter ended June 30, 2021(Q1). Further, in terms of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, and in accordance with Company's internal code of conduct for prevention of insider trading, the Trading Window for dealing in the securities of the Company has been closed for Directors/ Officers and designated employees of the Company from July 1, 2021 and shall remain closed till the expiry of 48 hours from the announcement/ declaration of the un-audited financial results of the Company for the quarter ended June 30, 2021.
The above information is a part of company’s filings submitted to BSE.
